Xcout Intel
Newbury Pharmaceuticals
Newbury Pharmaceuticals is a hybrid pharmaceutical company operating primarily in the Nordic region that commercializes and distributes a diverse portfolio of medicines. The company acts as a marketing authorization holder and exclusive local representative for international partners, providing high-quality pharmaceutical products across multiple therapeutic areas.
Subscribe to see Newbury Pharmaceuticals’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Newbury Pharmaceuticals at a glance
Newbury Pharmaceuticals is a health care company headquartered in Sweden. Xcout tracks 3 named people at Newbury Pharmaceuticals, including Christoffer Tell (CFO).
Newbury Pharmaceuticals leadership
- Christoffer TellCFO
- Karl KarlssonFounder & CEO
- Fredrik HellqvistGeneral Manager Nordic
Newbury Pharmaceuticals competitors
A few of Newbury Pharmaceuticals's closest competitors — see the full list of competitors and alternatives →
Stenocare is a publicly traded pharmaceutical company that innovates, imports, and distributes prescription-based medical cannabis products. The company serves patients and healthcare providers in Northern Europe and Australia by supplying regulated, pharmaceutical-grade cannabis treatments for pain and various other conditions.
A.forall is a Belgian group of pharmaceutical companies headquartered in Anderlecht with offices in Ireland and the United States, serving as a pharmaceutical licensing and distribution partner.
Navamedic is a Nordic pharmaceutical company that supplies and distributes prescription medicines, consumer health products, and medical nutrition. The company serves patients and healthcare providers by offering specialized treatments, nutritional support, and in-licensed healthcare products across multiple countries.
Hyphens Pharma International Limited is a Singapore-headquartered pharmaceutical company that develops, licenses, distributes, and markets pharmaceutical and healthcare products. It serves healthcare professionals, hospitals, pharmacies, and consumers across Singapore and other Southeast Asian markets, with a focus on specialty and branded products.
CMP Pharma is a specialty pharmaceutical company that develops and manufactures high-value branded and generic oral liquids, semi-solid topical products, and non-prescription pharmaceuticals. The company serves hospitals, long-term care facilities, and retail channels to provide customized care and alternative formulations for patient populations with unmet needs, such as those with difficulty swallowing.
Biomedica Management Corp is a pharmaceutical company that specializes in the commercialization, distribution, and in-licensing of rare disease and innovative therapies in emerging and underserved markets. It provides biopharmaceutical partners with comprehensive services including market access strategies, regulatory navigation, and reimbursement solutions to expand patient access to breakthrough treatments.
Get Newbury Pharmaceuticals's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Newbury Pharmaceuticals in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access